Meet The Speakers
The CINP2023 Scientific Programme Committee is pleased to announce the following congress speakers.
To find out more about each speaker, please click on the pictures below.
Oliver Howes is Professor of Molecular Psychiatry at King’s and Imperial Colleges, London. His clinical work is as Consultant Psychiatrist at The Maudsley Hospital, where he runs a service for people with psychoses.
His research interests centre on the causes and treatment of affective and psychotic disorders. His recent work has focussed on understanding the role of dopamine and neuroinflammation in the development of psychosis, the effects of antipsychotic drugs, & the causes of cognitive impairments.
His work has been recognised through a number of awards including the American College of Neuropsychopharmacology Joel Elkes Award (2022), Royal College of Psychiatrists Researcher of the Year Award (2017), Schizophrenia International Research Society Rising Star Award (2013). Web of Science named him as one of the most influential researchers in the world over the last decade.
Other career highlights include working as a junior potato scrubber on a farm. He spends his spare time trying to find the world’s best ice-cream.
I am Professor of Psychiatry, Associate Head of Department (Research), and Chair of the University of Oxford Neuroscience Committee. I trained in Oxford and London, and was a Wellcome Trust Senior Research Fellow before being appointed to my present post in 1997. I head a research group investigating molecular, psychopharmacological and therapeutic aspects of mood disorders and schizophrenia – and now the neuropsychiatric aspects of COVID-19. I have published 350 papers and several books. My clinical work centres on mood disorders. I am a Deputy Editor for Biological Psychiatry. I have served on various funding committees, chaired an NHS Research Ethics Committee, and was Treasurer for the Academic Faculty of the Royal College of Psychiatrists. I have supervised 24 PhDs. Awards include the CINP/Paul Janssen Schizophrenia Prize (1998), the British Association for Psychopharmacology Senior Clinical Prize (1999), the A.E. Bennett Award of the Society of Biological Psychiatry (2004), the Joel Elkes Research Award of the American College of Neuropsychopharmacology (2005), the CINP Lilly Clinical Neuroscience award (2010), and the ECNP Clinical Neuropsychopharmacology award (2012). I was President of the British Association for Psychopharmacology from 2014-2016.
Dr. Frangou is Chair in Brain Health at the University of British Columbia and Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai. Her work focuses on elucidating the brain correlates of psychopathology and cognition across the lifespan in healthy individuals and persons with schizophrenia and bipolar disorder. She is editor-in-chief of European Psychiatry, and Human Brain Mapping. Dr. Frangou has published over 300 articles and has received numerous awards including the 2019 Colvin Prize for Outstanding Achievement in Mood Disorders Research from the Brain and Behavior Research Foundation and the 2020 Educator Award and the 2022 George N. Thompson Award, both from the society of Biological Psychiatry.